share_log

Stephens & Co. Downgrades Lifecore Biomedical to Equal-Weight, Lowers Price Target to $2

Benzinga ·  Mar 20, 2023 08:21

Stephens & Co. analyst Jacob Johnson downgrades Lifecore Biomedical (NASDAQ:LFCR) from Overweight to Equal-Weight and lowers the price target from $11 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment